サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1453663

ヘパリン原薬の世界市場：シェアとランキング、全体の売上と需要予測（2024年～2030年）

Heparin Active Pharmaceutical Ingredients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
出版日: | 発行: QYResearch | ページ情報: 英文 162 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヘパリン原薬の世界市場：シェアとランキング、全体の売上と需要予測（2024年～2030年）
出版日: 2024年03月20日
発行: QYResearch
ページ情報: 英文 162 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヘパリン原薬の市場規模は、2023年に17億8,000万米ドルとなりました。

同市場は、2024年～2030年に7.79%のCAGRで拡大し、2030年には28億8,000万米ドルに達すると予測されています。

北米のヘパリン原薬の市場規模は、2023年に5億8,213万米ドルとなりました。同市場は、2024年～2030年の予測期間中に7.61％のCAGRで拡大し、2030年までに9億2,308万米ドルに達すると予測されています。

アジア太平洋のヘパリン原薬の市場規模は、2023年に5億6,254万米ドルとなりました。同市場は、2024年～2030年の予測期間中に8.83％のCAGRで拡大し、2030年までに9億7,217万米ドルに達すると予測されています。

欧州のヘパリン原薬の市場規模は、2023年に6億1,131万米ドルとなりました。同市場は、2024年～2030年の予測期間中に7.04％のCAGRで拡大し、2030年までに9億5,268万米ドルに達すると予測されています。

ヘパリン原薬の世界の主要企業には、Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Nanjing King-friend Biochemical Pharmaceutical、Pfizer、Hebei Changshan Biochemical Pharmaceutical、Bioiberica、Qingdao Jiulong Biopharmaceutical、Changzhou Qianhong Biopharma、Dongying Tiandong Pharmaceuticalなどが含まれます。2023年には、世界の大手5社が収益で約54.92%のシェアを占めています。

当レポートでは、世界のヘパリン原薬市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場概要

  • ヘパリン原薬製品概要
  • 世界のヘパリン原薬市場規模予測
  • ヘパリン原薬市場動向と促進要因
  • 前提と制限
  • 調査目的
  • 対象年

第2章 企業による競合分析

第3章 タイプ別セグメント

  • イントロダクション、タイプ別
  • 世界のヘパリン原薬の販売額、タイプ別
  • 世界のヘパリン原薬の販売量、タイプ別
  • 世界のヘパリン原薬の平均価格（2019年～2030年）、タイプ別

第4章 用途別セグメント

  • イントロダクション、用途別
  • 世界のヘパリン原薬の販売額、用途別
  • 世界のヘパリン原薬の販売量、用途別
  • 世界のヘパリン原薬の平均価格（2019年～2030年）、用途別

第5章 地域別セグメンテーション

  • 世界のヘパリン原薬の販売額、地域別
  • 世界のヘパリン原薬の販売量、地域別
  • 世界のヘパリン原薬の平均価格（2019年～2030年）、地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第6章 主要国/地域別セグメンテーション

  • ヘパリン原薬、販売額、成長動向、2019年 VS 2023年 VS 2030年、主要国/地域別
  • ヘパリン原薬、販売額、主要国/地域別
  • 米国
  • 欧州
  • 中国
  • 日本
  • インド

第7章 企業プロファイル

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

第8章 産業チェーン分析

  • ヘパリン原薬の産業チェーン
  • ヘパリン有効医薬品成分の上流分析
  • 中流分析
  • 下流分析（顧客分析）
  • 販売モデルと販売チャネル

第9章 調査結果と結論

第10章 付録

図表

List of Tables

  • Table 1. Heparin Active Pharmaceutical Ingredients Market Trends
  • Table 2. Heparin Active Pharmaceutical Ingredients Market Drivers & Opportunity
  • Table 3. Heparin Active Pharmaceutical Ingredients Market Challenges
  • Table 4. Heparin Market Restraints
  • Table 5. Global Heparin Active Pharmaceutical Ingredients Revenue by Company (2019-2024) & (US$ Million)
  • Table 6. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Company (2019-2024)
  • Table 7. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Company (2019-2024) & (Billion Units)
  • Table 8. Global Heparin Active Pharmaceutical Ingredients Sales Volume Market Share by Company (2019-2024)
  • Table 9. Global Market Heparin Active Pharmaceutical Ingredients Price by Company (2019-2024) & (US$/Billion Units)
  • Table 10. Key Manufacturers Heparin Active Pharmaceutical Ingredients Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Heparin Active Pharmaceutical Ingredients Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Heparin Active Pharmaceutical Ingredients
  • Table 13. Global Heparin Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Active Pharmaceutical Ingredients as of 2023)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Heparin Active Pharmaceutical Ingredients Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 17. Global Heparin Active Pharmaceutical Ingredients Sales Value by Type (2019-2024) & (US$ Million)
  • Table 18. Global Heparin Active Pharmaceutical Ingredients Sales Value by Type (2025-2030) & (US$ Million)
  • Table 19. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Type (2019-2024)
  • Table 20. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Type (2025-2030)
  • Table 21. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type: 2019 VS 2023 VS 2030 (Billion Units)
  • Table 22. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type (2019-2024) & (Billion Units)
  • Table 23. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type (2025-2030) & (Billion Units)
  • Table 24. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Type (2019-2024)
  • Table 25. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Type (2025-2030)
  • Table 26. Global Heparin Active Pharmaceutical Ingredients Price by Type (2019-2024) & (US$/Billion Units)
  • Table 27. Global Heparin Active Pharmaceutical Ingredients Price by Type (2025-2030) & (US$/Billion Units)
  • Table 28. Detailed Description of Heparin API
  • Table 29. Global Heparin Active Pharmaceutical Ingredients Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 30. Global Heparin Active Pharmaceutical Ingredients Sales Value by Application (2019-2024) & (US$ Million)
  • Table 31. Global Heparin Active Pharmaceutical Ingredients Sales Value by Application (2025-2030) & (US$ Million)
  • Table 32. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Application (2019-2024)
  • Table 33. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Application (2025-2030)
  • Table 34. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application: 2019 VS 2023 VS 2030 (Billion Units)
  • Table 35. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application (2019-2024) & (Billion Units)
  • Table 36. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application (2025-2030) & (Billion Units)
  • Table 37. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Application (2019-2024)
  • Table 38. Global Heparin Active Pharmaceutical Ingredients Sales Market Share in Value by Application (2025-2030)
  • Table 39. Global Heparin Active Pharmaceutical Ingredients Price by Application (2019-2024) & (US$/Billion Units)
  • Table 40. Global Heparin Active Pharmaceutical Ingredients Price by Application (2025-2030) & (US$/Billion Units)
  • Table 41. Global Heparin Active Pharmaceutical Ingredients Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
  • Table 42. Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2019-2024) & (US$ Million)
  • Table 43. Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2025-2030) & (US$ Million)
  • Table 44. Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2019-2024) & (%)
  • Table 45. Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2025-2030) & (%)
  • Table 46. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (Billion Units): 2019 VS 2023 VS 2030
  • Table 47. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2019-2024) & (Billion Units)
  • Table 48. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2025-2030) & (Billion Units)
  • Table 49. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2019-2024) & (%)
  • Table 50. Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2025-2030) & (%)
  • Table 51. Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2019-2024) & (US$/Billion Units)
  • Table 52. Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2025-2030) & (US$/Billion Units)
  • Table 53. Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
  • Table 54. Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2024) & (US$ Million)
  • Table 55. Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value, (2025-2030) & (US$ Million)
  • Table 56. Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Volume, (2019-2024) & (Billion Units)
  • Table 57. Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Volume, (2025-2030) & (Billion Units)
  • Table 58. Shenzhen Hepalink Pharmaceutical Corporation Information
  • Table 59. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
  • Table 60. Shenzhen Hepalink Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 61. Shenzhen Hepalink Pharmaceutical Heparin Product
  • Table 62. Yantai Dongcheng Pharmaceutical Corporation Information
  • Table 63. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
  • Table 64. Yantai Dongcheng Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 65. Yantai Dongcheng Pharmaceutical Heparin Product
  • Table 66. Pfizer Corporation Information
  • Table 67. Pfizer Introduction and Business Overview
  • Table 68. Pfizer Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 69. Pfizer Heparin Product
  • Table 70. Bioiberica Corporation Information
  • Table 71. Bioiberica Introduction and Business Overview
  • Table 72. Bioiberica Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 73. Bioiberica Heparin Product
  • Table 74. Changzhou Qianhong Biopharma Corporation Information
  • Table 75. Changzhou Qianhong Biopharma Introduction and Business Overview
  • Table 76. Changzhou Qianhong Biopharma Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 77. Changzhou Qianhong Biopharma Heparin Product
  • Table 78. Nanjing King-friend Biochemical Pharmaceutical Corporation Information
  • Table 79. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
  • Table 80. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 81. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
  • Table 82. Hebei Changshan Biochemical Pharmaceutical Corporation Information
  • Table 83. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
  • Table 84. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 85. Hebei Changshan Biochemical Pharmaceutical Heparin Product
  • Table 86. Qingdao Jiulong Biopharmaceutical Corporation Information
  • Table 87. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
  • Table 88. Qingdao Jiulong Biopharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 89. Qingdao Jiulong Biopharmaceutical Heparin Product
  • Table 90. Opocrin Corporation Information
  • Table 91. Opocrin Introduction and Business Overview
  • Table 92. Opocrin Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 93. Opocrin Heparin Product
  • Table 94. Dongying Tiandong Pharmaceutical Corporation Information
  • Table 95. Dongying Tiandong Pharmaceutical Introduction and Business Overview
  • Table 96. Dongying Tiandong Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 97. Dongying Tiandong Pharmaceutical Heparin Product
  • Table 98. Aspen Oss Corporation Information
  • Table 99. Aspen Oss Introduction and Business Overview
  • Table 100. Aspen Oss Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 101. Aspen Oss Heparin Product
  • Table 102. Yino Pharma Corporation Information
  • Table 103. Yino Pharma Introduction and Business Overview
  • Table 104. Yino Pharma Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 105. Yino Pharma Heparin Product
  • Table 106. Nanjing Xinbai Pharmaceutical Corporation Information
  • Table 107. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
  • Table 108. Nanjing Xinbai Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 109. Nanjing Xinbai Pharmaceutical Heparin Product
  • Table 110. Hubei Enoray Biopharmaceutical Corporation Information
  • Table 111. Hubei Enoray Biopharmaceutical Introduction and Business Overview
  • Table 112. Hubei Enoray Biopharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 113. Hubei Enoray Biopharmaceutical Heparin Product
  • Table 114. Cisen Pharmaceutical Corporation Information
  • Table 115. Cisen Pharmaceutical Introduction and Business Overview
  • Table 116. Cisen Pharmaceutical Heparin Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
  • Table 117. Cisen Pharmaceutical Heparin Product
  • Table 118. Key Raw Materials Lists
  • Table 119. Raw Materials Key Suppliers Lists
  • Table 120. Heparin Active Pharmaceutical Ingredients Manufacturing Cost Structure
  • Table 121. Heparin Active Pharmaceutical Ingredients Downstream Customers
  • Table 122. Heparin Active Pharmaceutical Ingredients Distributors List
  • Table 123. Research Programs/Design for This Report
  • Table 124. Key Data Information from Secondary Sources
  • Table 125. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Heparin Active Pharmaceutical Ingredients Product Picture
  • Figure 2. Global Heparin Active Pharmaceutical Ingredients Sales Value, 2019 VS 2024 VS 2030 (US$ Million)
  • Figure 3. Global Heparin Active Pharmaceutical Ingredients Sales Value (2019-2030) & (US$ Million)
  • Figure 4. Global Heparin Active Pharmaceutical Ingredients Sales Volume (2019-2030) & (Billion Units)
  • Figure 5. Global Heparin Active Pharmaceutical Ingredients Sales Price (2019-2030) & (US$/Billion Units)
  • Figure 6. Heparin Active Pharmaceutical Ingredients Report Years Considered
  • Figure 7. Global Heparin Active Pharmaceutical Ingredients Players Revenue Share Ranking (2023)
  • Figure 8. Global Heparin Active Pharmaceutical Ingredients Players Sales Volume Share Ranking (2023)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Active Pharmaceutical Ingredients Revenue in 2023
  • Figure 10. Heparin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 11. Heparin Sodium Picture
  • Figure 12. Heparin Calcium Picture
  • Figure 13. Global Heparin Active Pharmaceutical Ingredients Sales Value Market Share by Type, 2023 & 2030
  • Figure 14. Global Heparin Active Pharmaceutical Ingredients Sales Volume Market Share by Type, 2023 & 2030
  • Figure 15. Product Picture of UFH
  • Figure 16. Product Picture of LMWH
  • Figure 17. Global Heparin Active Pharmaceutical Ingredients Sales Value Market Share by Application, 2023 & 2030
  • Figure 18. Global Heparin Active Pharmaceutical Ingredients Sales Volume Market Share by Application, 2023 & 2030
  • Figure 19. North America Heparin Active Pharmaceutical Ingredients Sales Value (2019-2030) & (US$ Million)
  • Figure 20. North America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • Figure 21. Europe Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 22. Europe Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • Figure 23. Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 24. Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), 2023 VS 2030
  • Figure 25. Latin America Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 26. Latin America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • Figure 27. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 28. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • Figure 29. United States Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 30. United States Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
  • Figure 31. United States Heparin Active Pharmaceutical Ingredients Sales Value by Application (%), 2023 VS 2030
  • Figure 32. Europe Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 33. Europe Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
  • Figure 34. Europe Heparin Active Pharmaceutical Ingredients Sales Value by Application (%), 2023 VS 2030
  • Figure 35. China Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 36. China Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
  • Figure 37. China Heparin Active Pharmaceutical Ingredients Sales Value by Application (%), 2023 VS 2030
  • Figure 38. Japan Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 39. Japan Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
  • Figure 40. Japan Heparin Active Pharmaceutical Ingredients Sales Value by Application (%), 2023 VS 2030
  • Figure 41. India Heparin Active Pharmaceutical Ingredients Sales Value, (2019-2030) & (US$ Million)
  • Figure 42. India Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
  • Figure 43. India Heparin Active Pharmaceutical Ingredients Sales Value by Application (%), 2023 VS 2030
  • Figure 44. Heparin Active Pharmaceutical Ingredients Industrial Chain
  • Figure 45. Number of Pigs Worldwide from 2012 to 2023 (in million head)
  • Figure 46. Number of Pigs Worldwide in April 2023, by Leading Country (in million head)
  • Figure 47. Channels of Distribution
  • Figure 48. Bottom-up and Top-down Approaches for This Report
  • Figure 49. Data Triangulation
  • Figure 50. Key Executives Interviewed
目次

The global market for Heparin Active Pharmaceutical Ingredients was estimated to be worth US$ 1.78 billion in 2023 and is forecast to a readjusted size of US$ 2.88 billion by 2030 with a CAGR of 7.79% during the forecast period 2024-2030.

North American market for Heparin Active Pharmaceutical Ingredients was valued at $ 582.13 million in 2023 and will reach $ 923.08 million by 2030, at a CAGR of 7.61% during the forecast period of 2024 through 2030.

Asia-Pacific market for Heparin Active Pharmaceutical Ingredients was valued at $ 562.54 million in 2023 and will reach $ 972.17 million by 2030, at a CAGR of 8.83% during the forecast period of 2024 through 2030.

Europe market for Heparin Active Pharmaceutical Ingredients was valued at $ 611.31 million in 2023 and will reach $ 952.68 million by 2030, at a CAGR of 7.04% during the forecast period of 2024 through 2030.

The global key companies of Heparin Active Pharmaceutical Ingredients include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioiberica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and Dongying Tiandong Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately 54.92% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Heparin Active Pharmaceutical Ingredients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin Active Pharmaceutical Ingredients by region & country, by Type, and by Application.

The Heparin Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Active Pharmaceutical Ingredients.

Market Segmentation

By Company

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

Segment by Type

  • Heparin Sodium
  • Heparin Calcium

Segment by Application

  • LMWH
  • UFH

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • Other
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Other
  • Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Heparin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Heparin Active Pharmaceutical Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Heparin Active Pharmaceutical Ingredients in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Heparin Active Pharmaceutical Ingredients Product Introduction
  • 1.2 Global Heparin Active Pharmaceutical Ingredients Market Size Forecast
    • 1.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value (2019-2030)
    • 1.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume (2019-2030)
    • 1.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Price (2019-2030)
  • 1.3 Heparin Active Pharmaceutical Ingredients Market Trends & Drivers
    • 1.3.1 Heparin Active Pharmaceutical Ingredients Industry Trends
    • 1.3.2 Heparin Active Pharmaceutical Ingredients Market Drivers & Opportunity
    • 1.3.3 Heparin Active Pharmaceutical Ingredients Market Challenges
    • 1.3.4 Heparin Active Pharmaceutical Ingredients Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Heparin Active Pharmaceutical Ingredients Players Revenue Ranking (2023)
  • 2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Company (2019-2024)
  • 2.3 Global Heparin Active Pharmaceutical Ingredients Players Sales Volume Ranking (2023)
  • 2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Company Players (2019-2024)
  • 2.5 Global Heparin Active Pharmaceutical Ingredients Average Price by Company (2019-2024)
  • 2.6 Key Manufacturers Heparin Active Pharmaceutical Ingredients Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Heparin Active Pharmaceutical Ingredients Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Heparin Active Pharmaceutical Ingredients
  • 2.9 Heparin Active Pharmaceutical Ingredients Market Competitive Analysis
    • 2.9.1 Heparin Active Pharmaceutical Ingredients Market Concentration Rate (2019-2024)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Active Pharmaceutical Ingredients Revenue in 2023
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Active Pharmaceutical Ingredients as of 2023)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Heparin Sodium
    • 3.1.2 Heparin Calcium
  • 3.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type
    • 3.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type (2019 VS 2023 VS 2030)
    • 3.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (2019-2030)
    • 3.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (%) (2019-2030)
  • 3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type
    • 3.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type (2019 VS 2023 VS 2030)
    • 3.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (2019-2030)
    • 3.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (%) (2019-2030)
  • 3.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2019-2030)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 UFH
    • 4.1.2 LMWH
  • 4.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application
    • 4.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application (2019 VS 2023 VS 2030)
    • 4.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (2019-2030)
    • 4.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (%) (2019-2030)
  • 4.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application
    • 4.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application (2019 VS 2023 VS 2030)
    • 4.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (2019-2030)
    • 4.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (%) (2019-2030)
  • 4.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2019-2030)

5 Segmentation by Region

  • 5.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region
    • 5.1.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region: 2019 VS 2023 VS 2030
    • 5.1.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2019-2024)
    • 5.1.3 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2025-2030)
    • 5.1.4 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), (2019-2030)
  • 5.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region
    • 5.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region: 2019 VS 2023 VS 2030
    • 5.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2019-2024)
    • 5.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2025-2030)
    • 5.2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (%), (2019-2030)
  • 5.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2019-2030)
  • 5.4 North America
    • 5.4.1 North America Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 5.4.2 North America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • 5.5 Europe
    • 5.5.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 5.5.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 5.6.2 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), 2023 VS 2030
  • 5.7 Latin America
    • 5.7.1 Latin America Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 5.7.2 Latin America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 5.8.2 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value Growth Trends, 2019 VS 2023 VS 2030
  • 6.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value
    • 6.2.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 6.2.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Volume, 2019-2030
  • 6.3 United States
    • 6.3.1 United States Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 6.3.2 United States Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
    • 6.3.3 United States Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030
  • 6.4 Europe
    • 6.4.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 6.4.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
    • 6.4.3 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030
  • 6.5 China
    • 6.5.1 China Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 6.5.2 China Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
    • 6.5.3 China Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030
  • 6.6 Japan
    • 6.6.1 Japan Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 6.6.2 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
    • 6.6.3 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030
  • 6.7 India
    • 6.7.1 India Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030
    • 6.7.2 India Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030
    • 6.7.3 India Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030

7 Company Profiled

  • 7.1 Shenzhen Hepalink Pharmaceutical
    • 7.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
    • 7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
    • 7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Products Offered
  • 7.2 Yantai Dongcheng Pharmaceutical
    • 7.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
    • 7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
    • 7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.2.4 Yantai Dongcheng Pharmaceutical Heparin Products Offered
  • 7.3 Pfizer
    • 7.3.1 Pfizer Corporation Information
    • 7.3.2 Pfizer Introduction and Business Overview
    • 7.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.3.4 Pfizer Heparin Products Offered
  • 7.4 Bioiberica
    • 7.4.1 Bioiberica Corporation Information
    • 7.4.2 Bioiberica Introduction and Business Overview
    • 7.4.3 Bioiberica Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.4.4 Bioiberica Heparin Products Offered
  • 7.5 Changzhou Qianhong Biopharma
    • 7.5.1 Changzhou Qianhong Biopharma Corporation Information
    • 7.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview
    • 7.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.5.4 Changzhou Qianhong Biopharma Heparin Products Offered
  • 7.6 Nanjing King-friend Biochemical Pharmaceutical
    • 7.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
    • 7.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
    • 7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered
  • 7.7 Hebei Changshan Biochemical Pharmaceutical
    • 7.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
    • 7.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
    • 7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered
  • 7.8 Qingdao Jiulong Biopharmaceutical
    • 7.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information
    • 7.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
    • 7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Products Offered
  • 7.9 Opocrin
    • 7.9.1 Opocrin Corporation Information
    • 7.9.2 Opocrin Introduction and Business Overview
    • 7.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.9.4 Opocrin Heparin Products Offered
  • 7.10 Dongying Tiandong Pharmaceutical
    • 7.10.1 Dongying Tiandong Pharmaceutical Corporation Information
    • 7.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
    • 7.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.10.4 Dongying Tiandong Pharmaceutical Heparin Products Offered
  • 7.11 Aspen Oss
    • 7.11.1 Aspen Oss Corporation Information
    • 7.11.2 Aspen Oss Introduction and Business Overview
    • 7.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.11.4 Aspen Oss Heparin Products Offered
  • 7.12 Yino Pharma
    • 7.12.1 Yino Pharma Corporation Information
    • 7.12.2 Yino Pharma Introduction and Business Overview
    • 7.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.12.4 Yino Pharma Heparin Products Offered
  • 7.13 Nanjing Xinbai Pharmaceutical
    • 7.13.1 Nanjing Xinbai Pharmaceutical Corporation Information
    • 7.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
    • 7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.13.4 Nanjing Xinbai Pharmaceutical Heparin Products Offered
  • 7.14 Hubei Enoray Biopharmaceutical
    • 7.14.1 Hubei Enoray Biopharmaceutical Corporation Information
    • 7.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
    • 7.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.14.4 Hubei Enoray Biopharmaceutical Heparin Products Offered
  • 7.15 Cisen Pharmaceutical
    • 7.15.1 Cisen Pharmaceutical Corporation Information
    • 7.15.2 Cisen Pharmaceutical Introduction and Business Overview
    • 7.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
    • 7.15.4 Cisen Pharmaceutical Heparin Products Offered

8 Industry Chain Analysis

  • 8.1 Heparin Active Pharmaceutical Ingredients Industrial Chain
  • 8.2 Heparin Active Pharmaceutical Ingredients Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Heparin Active Pharmaceutical Ingredients Sales Model
    • 8.5.2 Heparin Active Pharmaceutical Ingredients Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
    • 10.1.2 Data Source
  • 10.2 Author Details
  • 10.3 Disclaimer